Understanding JAK Inhibitor Treatment Strategies for Patients with Myeloproliferative Neoplasms

Time: 11:00 am
day: Day One

Details:

  • Rationale for JAK inhibition in MPN
  • Success and limitations of JAK inhibitors in MPN
  • Modern JAK inhibitor-based combination therapy approaches

Speakers: